Integrated Biopharma Inc (INBP): EPS (Basic)
$0.03
Year ended 2025-06-30
-38.7%
3-year compound annual growth
-26.5%
5-year compound annual growth
0.0%
10-year compound annual growth
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $0.03 | n/a | 2025-09-23, From 2024-07-01 |
| 2024-06-30 | $0.00 | n/a | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | $0.00 | -100.0% | 2024-09-20, From 2022-07-01 |
| 2022-06-30 | $0.13 | -51.9% | 2023-09-15, From 2021-07-01 |
| 2021-06-30 | $0.27 | +92.9% | 2022-09-13, From 2020-07-01 |
| 2020-06-30 | $0.14 | +133.3% | 2021-09-02, From 2019-07-01 |
| 2019-06-30 | $0.06 | +100.0% | 2020-09-23, From 2018-07-01 |
| 2018-06-30 | $0.03 | -72.7% | 2019-08-29, From 2017-07-01 |
| 2017-06-30 | $0.11 | +120.0% | 2018-09-12, From 2016-07-01 |
| 2016-06-30 | $0.05 | +66.7% | 2017-09-01, From 2015-07-01 |
| 2015-06-30 | $0.03 | +200.0% | 2016-09-02, From 2014-07-01 |
| 2014-06-30 | $0.01 | n/a | 2015-09-04, From 2013-07-01 |
| 2013-06-30 | $0.00 | n/m | 2014-09-08, From 2012-07-01 |
| 2012-06-30 | -$0.13 | n/a | 2013-09-30, From 2011-07-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Integrated Biopharma Inc (INBP) | 2025-06-30 | $0.03 | n/a |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | -$7.12 | n/m |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $2.42 | n/m |
| Nektar Therapeutics (NKTR) | 2025-12-31 | -$9.73 | n/m |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | -$1.42 | n/m |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | -$1.16 | n/m |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | -$0.14 | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$0.75 | n/m |
| Journey Medical Corp (DERM) | 2025-12-31 | -$0.47 | n/m |
Compare INBP, AGIO, QTTB, NKTR side by side · Screen every company in Pharmaceutical Preparations ↗